WASHINGTON, Sept. 19, 2013 /PRNewswire-USNewswire/ -- Cancer Clinics of Excellence will be convening our 7th Annual Fall Meeting and Clinical Congress tonight at the Renaissance Hotel at 999 9th St NW, Washington, DC in the Grand Ballroom North. Our keynote speaker is Sharyl Nass, PhD, Director of Cancer Policy at the Institute of Medicine. Dr. Nass will be sharing the results of their new project report on Delivering High Quality Cancer Care: Charting a New Course for a System in Crisis IOM Project Study Report. We will follow that session with a panel discussion on how CCE is implementing many of these initiatives in the community setting.

The meeting will continue on Friday and Saturday with the following speakers and topics:

• Improving Cancer Outcomes Through Disruptive Next-Gen Technologies - Dietrich Stephan, PhD, Founder, President, and CEO, Silicon Valley Biosystems
• Chimeric Antigen Receptors - Modified T Cells for Acute Lymphoid Leukemia -  Noelle Frey, MD, MS, University of Pennsylvania
• Integration of Genetics, Genomics and Biology in Personalize Medicine - Jeffrey Trent, PhD, President and Research Director of the Translational Genomic Research Institute
• Detection of Circulating Tumor Cell-Free DNA – Helmy Eltoukhy, Founder; Michael Wiley, CFO, Guardant
• PD1 and Its Ligands in Tolerance and Immunity - Patrick A. Ott, MD, PhD, Clinical Director, Melanoma Disease Center, Dana Farber Cancer Institute
• Big Data's Impact on Evidence-based Cancer Care- Nat Turner, Co-Founder, Zach Weinberg, Co-Founder, Robin Shah, Flatiron Health
• Clinical Trials Patient Stratification – A Live Tumor Board – Chris Corless, MD, PhD, Knight Diagnostic Laboratories, Oregon Health Sciences University

SOURCE Cancer Clinics of Excellence